semaglutide gastric intestinal obstruction law office in louisiana glp-1 gastroparesis law office louisiana Ozempic Lawsuit: May 2026 Blindness and Gastroparesis louisiana semaglutide gastric intestinal obstruction – louisiana semaglutide gastric intestinal obstruction

- Not FDA-approved for human use commonly available through research and compounding pharmacies

2021 (STEP 1)

Surprisingly this was independent of increased muscle mass or linear growth (Fig 2A-D, 2K), and of any other effect of semaglutide treatment on the somatotropic growth axis of CD mice (Fig 3B-E)

doi: 10.1038/s41429-021-00463-w 166 HuangJ.HuP.YeL.ShenZ.ChenX.LiuF.et al

At the same time, the true incidence is genuinely unknown and contested, and there is a clear nocebo component: in one study, 44% of men told about sexual side effects reported them, versus 15% of men who were not told (the study used the 5 mg prostate dose rather than the 1 mg hair-loss dose, but the pattern is striking)